Benazepril


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult: PO HTN Initial: 10 mg once daily. Maintenance: 20-40 mg/day as a single or in 2 divided doses. Max: 80 mg/day. Heart failure Initial: 2.5 mg once daily. Max: 20 mg/day.
Administration
May be taken with or without food.
Contraindications
History of angioedema due to previous ACE inhibitor treatment. Pregnancy.
Special Precautions
Patients w/ diarrhoea, severe volume and/or salt depletion, unilateral or bilateral renal artery stenosis. Patients on dietary salt restriction and dialysis. Increased risk of angioedema in black patients. Renal impairment. Lactation. Patient Counselling May impair ability to drive and operate machinery. Monitoring Parameters Monitor BP. Periodic monitoring of serum creatinine, and K levels.
Adverse Reactions
Headache, dizziness, fatigue, persistent and non productive cough, somnolence, nausea, transient elevations in BUN and serum creatinine, hyperkalaemia. Intestinal angioedema.
Potentially Fatal: Anaphylactoid reactions and angioedema. Cholestatic jaundice which may progress to fulminant hepatic necrosis.
Drug Interactions
Additive hyperkalaemic effects w/ K-sparing diuretics, K supplements, other drugs that can cause hyperkalaemia. May increase lithium concentration and toxicity.
ATC Classification
C09AA07 - benazepril ; Belongs to the class of ACE inhibitors. Used in the treatment of cardiovascular disease.
Disclaimer: This information is independently developed by CIMS based on benazepril from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in